Direkt zum Inhalt
Merck

AIF downregulation and its interaction with STK3 in renal cell carcinoma.

PloS one (2014-07-06)
Shengqiang Xu, Hongjin Wu, Huan Nie, Lei Yue, Huadong Jiang, Sheng Xiao, Yu Li
ZUSAMMENFASSUNG

Apoptosis-inducing factor (AIF) plays a crucial role in caspase-independent programmed cell death by triggering chromatin condensation and DNA fragmentation. Therefore, it might be involved in cell homeostasis and tumor development. In this study, we report significant AIF downregulation in the majority of renal cell carcinomas (RCC). In a group of RCC specimens, 84% (43 out of 51) had AIF downregulation by immunohistochemistry stain. Additional 10 kidney tumors, including an oxyphilic adenoma, also had significant AIF downregulation by Northern blot analysis. The mechanisms of the AIF downregulation included both AIF deletion and its promoter methylation. Forced expression of AIF in RCC cell lines induced massive apoptosis. Further analysis revealed that AIF interacted with STK3, a known regulator of apoptosis, and enhanced its phosphorylation at Thr180. These results suggest that AIF downregulation is a common event in kidney tumor development. AIF loss may lead to decreased STK3 activity, defective apoptosis and malignant transformation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
L-Glutamin, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-Glutamin
SAFC
L-Glutamin
Sigma-Aldrich
L-Glutamin, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Anti-V5-Antikörper, Maus monoklonal, clone V5-10, purified from hybridoma cell culture
Sigma-Aldrich
L-Glutamin
Sigma-Aldrich
L-Glutamin, γ-irradiated, BioXtra, suitable for cell culture
Supelco
L-Glutamin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Glutamin, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Anti-STK3 antibody produced in rabbit, affinity isolated antibody